Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice
- PMID: 3089933
- PMCID: PMC260865
- DOI: 10.1128/iai.53.2.245-251.1986
Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice
Abstract
The BALB/c mouse was selected as a model for infection with Brucella abortus on the basis of protracted nonclinical infection produced by strain 2308, virulent for cattle, and relatively rapid clearance of strain 19, an attenuated strain used to vaccinate cattle. Protection in mice vaccinated with strain 19 was compared with that obtained with nonliving vaccines at early (1 week) and later (4 weeks) intervals after challenge with strain 2308 and assessed by enumeration of B. abortus organisms in the spleen. Mice challenged 4 weeks after vaccination with strain 19 exhibited significant protection at 1 and 4 weeks postinfection (p.i.), with an increased magnitude of protection at the later time. When challenged 6 weeks after vaccination with strain 19, the level of protection diminished between 1 and 4 weeks p.i. and at the later time was not always significantly different from controls. Mice immunized 4 weeks earlier with nonliving vaccines in mineral oil with t trehalose dimycolate (TDM) and muramyl dipeptide (MDP) demonstrated patterns of protection similar to those obtained following the 6 week vaccination-challenge interval with strain 19. Vaccination with cell envelopes derived from strain 2308 produced equivalent protection at 1 week p.i. whether administered in phosphate-buffered saline, incomplete Freund adjuvant, or the TDM and MDP adjuvant. Equivalent protection also followed vaccination with strain 2308 killed whole cells, cell envelopes, or outer membrane proteins in phosphate-buffered saline or in the TDM and MDP adjuvant. The TDM and MDP adjuvant alone induced nonspecific resistance, which peaked at 1 day p.i. and was still present at 1 week p.i., although by this time its magnitude was significantly less than the protection induced by antigen combined with the adjuvant. These data, together with the results of antibody assays and passive and adoptive transfer studies, suggested that protection at 1 week p.i. could be accounted for largely by an effect of O antibodies, with T cell-mediated immune responses having a subsidiary role.
Similar articles
-
Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants.Infect Immun. 1983 Dec;42(3):1159-67. doi: 10.1128/iai.42.3.1159-1167.1983. Infect Immun. 1983. PMID: 6315592 Free PMC article.
-
Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.Infect Immun. 1988 Nov;56(11):2808-17. doi: 10.1128/iai.56.11.2808-2817.1988. Infect Immun. 1988. PMID: 2844673 Free PMC article.
-
Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.Am J Vet Res. 1981 Nov;42(11):1959-62. Am J Vet Res. 1981. PMID: 6802042
-
Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.Infect Immun. 2001 Aug;69(8):4816-22. doi: 10.1128/IAI.69.8.4816-4822.2001. Infect Immun. 2001. PMID: 11447155 Free PMC article.
-
Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice.Vet Immunol Immunopathol. 1988 Mar;18(2):149-63. doi: 10.1016/0165-2427(88)90057-8. Vet Immunol Immunopathol. 1988. PMID: 3133872
Cited by
-
Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum.Infect Immun. 1990 Jan;58(1):254-6. doi: 10.1128/iai.58.1.254-256.1990. Infect Immun. 1990. PMID: 2104599 Free PMC article.
-
Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice.Infect Immun. 1992 Jul;60(7):2863-9. doi: 10.1128/iai.60.7.2863-2869.1992. Infect Immun. 1992. PMID: 1612752 Free PMC article.
-
Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice.Infect Immun. 2002 Dec;70(12):7004-12. doi: 10.1128/IAI.70.12.7004-7012.2002. Infect Immun. 2002. PMID: 12438380 Free PMC article.
-
Identification of genes required for chronic persistence of Brucella abortus in mice.Infect Immun. 2000 Jul;68(7):4102-7. doi: 10.1128/IAI.68.7.4102-4107.2000. Infect Immun. 2000. PMID: 10858227 Free PMC article.
-
Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.Infect Immun. 1998 Apr;66(4):1309-16. doi: 10.1128/IAI.66.4.1309-1316.1998. Infect Immun. 1998. PMID: 9529047 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources